Free Newsletter
Schering-Plough wins an EC approval
Schering-Plough says the EC has approved Bridion (sugammadex) injection, "the first and only selective relaxant binding agent and the first major pharmaceutical advance in the field of anesthesia in two decades." Release
Comments (1) | Post a comment
Comments
By Harvey Grove | Posted 2:51pm | September 22, 2008
I agree with FDA on most issues regarding approval of new drugs, however, a new anti clotting drug has a problem because the goal (increased clotting time) is the same as the risk (increased clotting time). What is the therapeutic index?
